Histogen Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2021. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-11-08: Reporting owner Mento Steven J; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-09-02: Reporting owner Jackson Jonathan; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-09-02: Reporting owner KISNER DANIEL L; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-09-02: Reporting owner Mento Steven J; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-11-08 | Mento Steven J Director, Officer (Interim President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +377,830 377,830 owned after | $0.73 exercise price | 2021-11-10 | |
| 2021-09-02 | Jackson Jonathan Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $0.82 exercise price | 2021-09-03 | |
| 2021-09-02 | KISNER DANIEL L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $0.82 exercise price | 2021-09-03 | |
| 2021-09-02 | Mento Steven J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $0.82 exercise price | 2021-09-03 | |
| 2021-09-02 | Crean David Hugh Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.82 exercise price | 2021-09-03 | |
| 2021-09-02 | Satz Brian Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $0.82 exercise price | 2021-09-03 | |
| 2021-03-25 | Fuhrmann Rochelle Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $1.27 exercise price | 2021-03-26 | |
| 2021-03-10 | Windham-Bannister Susan Richards Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $1.23 exercise price | 2021-03-12 | |
| 2021-01-13 | Pascoe Richard W Director, Officer (President, CEO & Director) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +346,000 346,000 owned after | $0.97 exercise price | 2021-01-15 | |
| 2021-01-13 | Naughton Gail K Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +95,000 95,000 owned after | $0.97 exercise price | 2021-01-15 | |
| 2021-01-13 | Latterich Martin Officer (SVP, Technical Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $0.97 exercise price | 2021-01-15 | |
| 2021-01-13 | Knudson Susan A. Officer (EVP, CFO & Corp Secy) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +112,000 112,000 owned after | $0.97 exercise price | 2021-01-15 | |
| 2021-01-13 | Daniels Moya Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $0.97 exercise price | 2021-01-15 |